C&R Research
씨엔알리서치 · 359090
Industrials Commercial Services · KOSDAQ
Market cap US$21.3M (₩29.4B)
Overview
C&R Research manages clinical trials on behalf of pharmaceutical companies and biotech ventures, handling everything from study design and protocol development through statistical analysis and regulatory reporting, so drug developers can outsource the research process entirely.
Listed on KOSDAQ, Korea's tech and small-cap board, it serves domestic pharmaceutical firms and biotech startups as its primary clients. Its business is knowledge-intensive and requires no physical facilities or raw materials, with revenue recognised progressively over the life of each contracted project.
Summary is AI-generated and may contain errors · figures from DART filings
Financials
Source: DART · FY ending Dec · latest FY2025Revenue
- FY2023US$39.9M
- FY2024US$43.3M
- FY2025US$47.1M
Operating profit
- FY2023US$4.5M
- FY2024US$2.6M
- FY2025US$1M
Net income
- FY2023US$4M
- FY2024US$2.4M
- FY2025US$740K
Key ratios (FY2025)
Why it matters
The company operates a subsidiary, Trial Informatics, to which it has transferred certain clinical-trial IT platform assets, running two distinct business lines, clinical trial services and clinical IT solutions, in parallel.
Price charts coming soon
Interactive price history isn't here yet. Would you use it?